US Bancorp’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26K | Sell |
342
-966
| -74% | -$9.2K | ﹤0.01% | 3749 |
|
|
2025
Q1 | $13.7K | Sell |
1,308
-301
| -19% | -$3.15K | ﹤0.01% | 3320 |
|
|
2024
Q4 | $37.9K | Buy |
1,609
+241
| +18% | +$5.68K | ﹤0.01% | 2885 |
|
|
2024
Q3 | $49.1K | Buy |
1,368
+1,212
| +777% | +$43.5K | ﹤0.01% | 2744 |
|
|
2024
Q2 | $5.51K | Hold |
156
| – | – | ﹤0.01% | 3468 |
|
|
2024
Q1 | $4.43K | Buy |
156
+77
| +97% | +$2.19K | ﹤0.01% | 3546 |
|
|
2023
Q4 | $1.05K | Buy |
79
+18
| +30% | +$239 | ﹤0.01% | 3780 |
|
|
2023
Q3 | $547 | Hold |
61
| – | – | ﹤0.01% | 3810 |
|
|
2023
Q2 | $686 | Hold |
61
| – | – | ﹤0.01% | 3815 |
|
|
2023
Q1 | $703 | Hold |
61
| – | – | ﹤0.01% | 3893 |
|
|
2022
Q4 | $707 | Hold |
61
| – | – | ﹤0.01% | 3941 |
|
|
2022
Q3 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 3912 |
|
|
2022
Q2 | – | Sell |
-407
| Closed | -$4K | – | 4079 |
|
|
2022
Q1 | $4K | Buy |
+407
| New | +$4K | ﹤0.01% | 3638 |
|